NASDAQ:BIIB - Biogen Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $306.13
  • Forecasted Upside: 25.42 %
  • Number of Analysts: 33
  • Breakdown:
  • 5 Sell Ratings
  • 15 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$244.09
▼ -2.83 (-1.15%)
1 month | 3 months | 12 months
Get New Biogen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BIIB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BIIB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$306.13
▲ +25.42% Upside Potential
This price target is based on 33 analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $306.13, with a high forecast of $450.00 and a low forecast of $175.00. The average price target represents a 25.42% upside from the last price of $244.09.
Hold
The current consensus among 33 contributing investment analysts is to hold stock in Biogen. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 11 buy ratings
  • 17 hold ratings
  • 5 sell ratings
6/12/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 17 hold ratings
  • 4 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 17 hold ratings
  • 5 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 17 hold ratings
  • 5 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 15 hold ratings
  • 4 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 16 hold ratings
  • 4 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 15 hold ratings
  • 4 sell ratings
11/3/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 15 hold ratings
  • 5 sell ratings
12/3/2020

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 15 hold ratings
  • 5 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/1/2020William BlairReiterated RatingMarket PerformLow
i
Rating by Matt Phipps at William Blair
12/1/2020Royal Bank of CanadaBoost Price TargetReduce ➝ Sector Perform$249.00 ➝ $256.00Low
i
11/19/2020Royal Bank of CanadaBoost Price TargetSector Perform$244.00 ➝ $249.00Low
i
11/10/2020TruistDowngradeBuy$310.00 ➝ $443.00Low
i
11/10/2020DZ BankUpgradeHold ➝ Buy$265.00Low
i
11/9/2020Royal Bank of CanadaLower Price TargetSector Perform$263.00 ➝ $244.00High
i
11/9/2020OppenheimerLower Price TargetOutperform$370.00 ➝ $330.00Medium
i
11/9/2020MizuhoLower Price TargetNeutral$282.00 ➝ $244.00Medium
i
Rating by Salim Syed at Mizuho
11/9/2020HC WainwrightLower Price TargetBuy$318.00 ➝ $289.00High
i
11/9/2020CowenDowngradeOutperform ➝ Market Perform$275.00 ➝ $215.00High
i
11/9/2020Bank of AmericaDowngradeNeutral ➝ Underperform$240.00High
i
11/9/2020Atlantic SecuritiesDowngradeNeutral ➝ Underweight$175.00High
i
11/5/2020Canaccord GenuityBoost Price TargetBuy$350.00 ➝ $393.00High
i
11/5/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$342.00 ➝ $402.00High
i
11/5/2020BMO Capital MarketsUpgradeMarket Perform$280.00 ➝ $343.00High
i
11/4/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$230.00 ➝ $360.00High
i
11/4/2020Jefferies Financial GroupUpgradeHold ➝ Buy$450.00High
i
11/4/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$437.00 ➝ $390.00High
i
11/3/2020Cantor FitzgeraldLower Price Target$339.00 ➝ $278.00Low
i
10/28/2020UBS GroupInitiated CoverageNeutral$268.00High
i
10/27/2020MizuhoLower Price TargetNeutral$316.00 ➝ $282.00Low
i
Rating by Salim Syed at Mizuho
10/22/2020HC WainwrightReiterated RatingBuyLow
i
10/22/2020OppenheimerLower Price TargetOutperform$360.00 ➝ $340.00Low
i
10/22/2020BarclaysLower Price TargetEqual Weight$275.00 ➝ $265.00Low
i
Rating by Carter Gould at Barclays PLC
10/22/2020WedbushLower Price TargetNeutral$281.00 ➝ $244.00Low
i
10/22/2020Credit Suisse GroupLower Price TargetOutperform$359.00 ➝ $350.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
10/22/2020Morgan StanleyBoost Price TargetOverweight$355.00 ➝ $357.00Low
i
Rating by Matthew Harrison at Morgan Stanley
10/20/2020Piper SandlerLower Price TargetNeutral$270.00 ➝ $265.00Low
i
10/19/2020Royal Bank of CanadaLower Price TargetSector Perform$281.00 ➝ $268.00High
i
10/15/2020Bank of AmericaLower Price TargetUnderperform$255.00 ➝ $235.00Low
i
10/13/2020Morgan StanleyLower Price TargetOverweight$357.00 ➝ $355.00Low
i
Rating by Matthew Harrison at Morgan Stanley
9/29/2020Canaccord GenuityReiterated RatingBuy$396.00Low
i
9/18/2020Royal Bank of CanadaLower Price TargetSector Perform$284.00 ➝ $277.00High
i
9/13/2020JPMorgan Chase & Co.Reiterated RatingHoldHigh
i
8/19/2020SVB LeerinkLower Price TargetOutperform$350.00 ➝ $342.00Medium
i
Rating by M. Goodman at SVB Leerink LLC
8/7/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$270.00 ➝ $375.00Medium
i
8/7/2020OppenheimerBoost Price TargetOutperform$325.00 ➝ $360.00High
i
7/31/2020Raymond JamesReiterated RatingSellLow
i
Rating by Steven Seedhouse at Raymond James
7/29/2020JPMorgan Chase & Co.Reiterated RatingHold$279.00Low
i
7/27/2020Morgan StanleyUpgradeUnderweight ➝ Overweight$263.00 ➝ $357.00High
i
Rating by Matthew Harrison at Morgan Stanley
7/23/2020BMO Capital MarketsLower Price TargetMarket Perform$317.00 ➝ $280.00Low
i
7/22/2020MizuhoReiterated RatingHold$316.00Low
i
Rating by Salim Syed at Mizuho
7/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$311.00 ➝ $324.00Low
i
7/22/2020Stifel NicolausLower Price TargetPositive ➝ Hold$294.00 ➝ $284.00Medium
i
7/16/2020OppenheimerReiterated RatingBuy$325.00Low
i
7/15/2020Morgan StanleyLower Price TargetUnderweight$301.00 ➝ $263.00Low
i
Rating by Matthew Harrison at Morgan Stanley
7/13/2020The Goldman Sachs GroupLower Price TargetNeutral$300.00 ➝ $257.00Medium
i
7/10/2020William BlairReiterated RatingHoldLow
i
Rating by Matt Phipps at William Blair
7/8/2020SunTrust BanksReiterated RatingBuy$330.00Low
i
Rating by Robyn Karnauskas at SunTrust Banks, Inc.
7/8/2020GuggenheimReiterated RatingBuy$390.00Low
i
Rating by Yatin Suneja at Guggenheim
7/6/2020Royal Bank of CanadaReiterated RatingHold$276.00Low
i
6/25/2020Credit Suisse GroupReiterated RatingHold$270.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
6/22/2020Royal Bank of CanadaLower Price TargetSector Perform$303.00 ➝ $273.00Low
i
6/22/2020BarclaysDowngradeOverweight ➝ Equal Weight$370.00 ➝ $280.00Low
i
6/19/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
i
6/19/2020William BlairReiterated RatingHoldHigh
i
6/19/2020Robert W. BairdLower Price TargetUnderperform$290.00 ➝ $228.00High
i
Rating by Brian Skorney at Robert W. Baird
6/19/2020Credit Suisse GroupLower Price TargetNeutral$310.00 ➝ $270.00High
i
Rating by Evan Seigerman at Credit Suisse Group AG
6/19/2020Piper SandlerLower Price TargetNeutral$307.00 ➝ $260.00High
i
6/18/2020MizuhoReiterated RatingHold$316.00High
i
Rating by Salim Syed at Mizuho
6/9/2020Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$360.00 ➝ $297.00Medium
i
5/28/2020Morgan StanleyReiterated RatingSell$301.00Low
i
Rating by Matthew Harrison at Morgan Stanley
5/1/2020Cantor FitzgeraldReiterated RatingNeutral$361.00 ➝ $308.00Low
i
4/30/2020Royal Bank of CanadaReiterated RatingHold$310.00High
i
Rating by Brian Abrahams at Royal Bank of Canada
4/24/2020William BlairReiterated RatingHoldHigh
i
4/24/2020Canaccord GenuityLower Price TargetBuy$360.00 ➝ $350.00Medium
i
Rating by Sumant Kulkarni at Canaccord Genuity
4/23/2020Morgan StanleyLower Price TargetUnderweight$302.00 ➝ $301.00Medium
i
4/23/2020SunTrust BanksLower Price TargetBuy$360.00 ➝ $330.00Medium
i
4/23/2020OppenheimerLower Price TargetOutperform$390.00 ➝ $365.00Low
i
4/23/2020Credit Suisse GroupLower Price TargetNeutral$344.00 ➝ $310.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
4/23/2020BarclaysLower Price TargetOverweight$389.00 ➝ $370.00Low
i
4/23/2020Royal Bank of CanadaLower Price TargetSector Perform$325.00 ➝ $310.00Low
i
Rating by Brian Abrahams at Royal Bank of Canada
4/23/2020CitigroupDowngradeNeutral ➝ Sell$365.00 ➝ $240.00Low
i
4/22/2020Raymond JamesDowngradeMarket Perform ➝ UnderperformMedium
i
Rating by Steven Seedhouse at Raymond James
4/22/2020Stifel NicolausLower Price TargetHold$296.00 ➝ $294.00High
i
4/22/2020WedbushLower Price TargetNeutral$306.00 ➝ $295.00High
i
4/22/2020MizuhoReiterated RatingHold$316.00High
i
4/8/2020SVB LeerinkReiterated RatingOutperformHigh
i
Rating by M. Goodman at SVB Leerink LLC
3/31/2020Wolfe ResearchInitiated CoverageMarket Perform$331.00Low
i
3/18/2020Royal Bank of CanadaReiterated RatingHold$335.00High
i
Rating by Brian Abrahams at Royal Bank of Canada
3/2/2020Canaccord GenuityReiterated RatingBuyHigh
i
Rating by Sumant Kulkarni at Canaccord Genuity
2/27/2020BarclaysInitiated CoverageOverweight$389.00High
i
2/25/2020MizuhoBoost Price TargetNeutral$300.00 ➝ $316.00Medium
i
2/11/2020William BlairReiterated RatingMarket PerformLow
i
2/7/2020OppenheimerBoost Price Target$338.00 ➝ $390.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
2/7/2020Nomura SecuritiesBoost Price TargetBuy$320.00 ➝ $392.00Low
i
2/6/2020BMO Capital MarketsReiterated RatingMarket Perform$317.00Low
i
2/6/2020Morgan StanleyBoost Price TargetUnderweight$261.00 ➝ $302.00Low
i
Rating by Matthew Harrison at Morgan Stanley
2/6/2020SVB LeerinkBoost Price TargetOutperform ➝ Positive$350.00 ➝ $410.00Medium
i
2/6/2020Credit Suisse GroupBoost Price TargetNeutral$300.00 ➝ $330.00Medium
i
Rating by Evan Seigerman at Credit Suisse Group AG
2/6/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$286.00 ➝ $311.00Low
i
2/6/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
2/6/2020Canaccord GenuityReiterated RatingBuy$360.00Medium
i
2/6/2020HC WainwrightReiterated RatingBuy$335.00Medium
i
Rating by Andrew Fein at HC Wainwright
2/6/2020Cantor FitzgeraldBoost Price TargetNeutral$315.00 ➝ $361.00Medium
i
2/5/2020MizuhoReiterated RatingHold$300.00Low
i
2/5/2020Robert W. BairdBoost Price TargetUnderperform ➝ Underperform$250.00 ➝ $290.00Low
i
Rating by Brian Skorney at Robert W. Baird
2/3/2020SVB LeerinkBoost Price TargetOutperform$350.00 ➝ $410.00High
i
Rating by M. Goodman at SVB Leerink LLC
2/3/2020SunTrust BanksBoost Price TargetBuy$337.00 ➝ $360.00Medium
i
2/2/2020Credit Suisse GroupReiterated RatingOverweight ➝ Hold$330.00 ➝ $300.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
1/31/2020Morgan StanleyLower Price TargetUnderweight$270.00 ➝ $261.00Low
i
Rating by Matthew Harrison at Morgan Stanley
1/31/2020Cantor FitzgeraldBoost Price TargetPositive ➝ Neutral$300.00 ➝ $315.00High
i
1/30/2020WedbushReiterated RatingNeutralHigh
i
1/30/2020JPMorgan Chase & Co.Reiterated RatingHoldLow
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/27/2020Royal Bank of CanadaReiterated RatingHold$285.00Low
i
Rating by Brian Abrahams at Royal Bank of Canada
1/27/2020Canaccord GenuityUpgradeHold ➝ Buy$305.00 ➝ $360.00Medium
i
1/23/2020Credit Suisse GroupReiterated RatingHold$300.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
1/23/2020Robert W. BairdReiterated RatingSell$250.00Low
i
Rating by Brian Skorney at Robert W. Baird
1/17/2020Morgan StanleyBoost Price TargetUnderweight$262.00 ➝ $270.00Low
i
Rating by Matthew Harrison at Morgan Stanley
1/2/2020CowenReiterated RatingBuy$325.00Low
i
12/13/2019Credit Suisse GroupUpgradeUnderperform ➝ Neutral$260.00 ➝ $300.00Medium
i
12/6/2019Raymond JamesReiterated RatingHoldLow
i
Rating by Steven Seedhouse at Raymond James
12/6/2019HC WainwrightReiterated RatingBuy$335.00Low
i
12/2/2019Robert W. BairdDowngradeNeutral ➝ Underperform$250.00Low
i
11/18/2019Royal Bank of CanadaReiterated RatingHold$267.00Medium
i
Rating by Brian Abrahams at Royal Bank of Canada
11/12/2019SunTrust BanksInitiated CoverageBuy$337.00Medium
i
11/1/2019Standpoint ResearchDowngradeBuy ➝ HoldLow
i
10/29/2019Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
i
10/25/2019William BlairReiterated RatingHoldLow
i
10/23/2019Bank of AmericaBoost Price TargetUnderperform$200.00 ➝ $235.00Low
i
10/23/2019Canaccord GenuityBoost Price TargetHold$285.00 ➝ $305.00Low
i
10/23/2019Credit Suisse GroupBoost Price TargetUnderperform$203.00 ➝ $260.00Low
i
10/23/2019JPMorgan Chase & Co.Boost Price TargetNeutral$244.00 ➝ $260.00Low
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
10/23/2019BMO Capital MarketsBoost Price TargetMarket Perform$250.00 ➝ $297.00Medium
i
10/23/2019CowenBoost Price TargetOutperform$275.00 ➝ $325.00High
i
10/23/2019Morgan StanleyBoost Price TargetUnderweight$212.00 ➝ $262.00High
i
Rating by Matthew Harrison at Morgan Stanley
10/23/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$256.00 ➝ $350.00High
i
Rating by G. Porges at SVB Leerink LLC
10/23/2019HC WainwrightBoost Price TargetBuy$300.00 ➝ $335.00High
i
10/23/2019GuggenheimUpgradeNeutral ➝ Buy$256.00 ➝ $365.00Medium
i
10/22/2019Jefferies Financial GroupBoost Price TargetHold$255.00 ➝ $310.00High
i
10/22/2019Stifel NicolausBoost Price TargetPositive ➝ Hold$236.00 ➝ $296.00High
i
10/22/2019UBS GroupBoost Price TargetOutperform ➝ Positive$280.00 ➝ $334.00High
i
10/22/2019CowenReiterated RatingOutperform$275.00 ➝ $325.00High
i
10/22/2019MizuhoReiterated RatingHold$235.00High
i
10/16/2019Bank of AmericaInitiated CoverageUnderperform$200.00Low
i
10/15/2019OppenheimerSet Price TargetBuy$280.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
10/11/2019Morgan StanleyBoost Price TargetUnderweight$211.00 ➝ $212.00Medium
i
9/23/2019JPMorgan Chase & Co.Set Price TargetHold$244.00Low
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
9/6/2019Royal Bank of CanadaSet Price TargetHold$242.00High
i
Rating by Brian Abrahams at Royal Bank of Canada
7/30/2019CowenReiterated RatingBuy$275.00Low
i
7/26/2019Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by Christopher Raymond at Piper Jaffray Companies
7/25/2019MizuhoReiterated RatingHoldLow
i
Rating by Salim Syed at Mizuho
7/24/2019Canaccord GenuityBoost Price TargetHold$275.00 ➝ $285.00Medium
i
Rating by Sumant Kulkarni at Canaccord Genuity
6/28/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$280.00 ➝ $250.00Medium
i
6/5/2019Standpoint ResearchUpgradeHold ➝ BuyLow
i
5/23/2019CitigroupReiterated RatingNeutral ➝ NeutralMedium
i
5/22/2019WedbushInitiated CoverageNeutral ➝ Neutral$231.00High
i
Rating by L. Chico at Wedbush
5/20/2019Credit Suisse GroupInitiated CoverageUnderperform$198.00Medium
i
5/9/2019BarclaysLower Price TargetEqual Weight$250.00 ➝ $245.00Medium
i
5/7/2019ArgusReiterated RatingHoldHigh
i
5/5/2019OppenheimerSet Price TargetBuy$290.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
4/24/2019JPMorgan Chase & Co.Reiterated RatingHoldHigh
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
4/22/2019OppenheimerSet Price TargetBuy$290.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
4/22/2019MizuhoSet Price TargetHold$235.00Low
i
Rating by Salim Syed at Mizuho
4/10/2019Raymond JamesInitiated CoverageMarket PerformLow
i
Rating by Laura Chico at Raymond James
3/27/2019Cantor FitzgeraldReiterated RatingHold$250.00Low
i
Rating by A. Young at Cantor Fitzgerald
3/25/2019Royal Bank of CanadaLower Price TargetSector Perform$236.00Low
i
3/25/2019HC WainwrightReiterated RatingBuy ➝ Buy$363.00 ➝ $300.00Low
i
3/22/2019GuggenheimSet Price TargetHold$236.00Medium
i
Rating by Yatin Suneja at Guggenheim
3/22/2019BarclaysReiterated RatingHold$250.00High
i
3/22/2019Nomura SecuritiesLower Price TargetBuy ➝ Buy$420.00 ➝ $320.00High
i
3/22/2019BMO Capital MarketsLower Price TargetMarket Perform$322.00 ➝ $250.00High
i
3/22/2019UBS GroupDowngradeBuy ➝ Neutral$395.00 ➝ $242.00High
i
3/22/2019Morgan StanleyDowngradeOverweight ➝ Underweight$401.00 ➝ $210.00High
i
3/21/2019CitigroupDowngradeBuy ➝ Neutral$470.00 ➝ $230.00High
i
3/21/2019Stifel NicolausReiterated RatingHold$346.00 ➝ $233.00High
i
3/21/2019Canaccord GenuityDowngradeBuy ➝ Hold$396.00 ➝ $275.00High
i
3/21/2019Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$400.00High
i
Rating by A. Young at Cantor Fitzgerald
3/21/2019The Goldman Sachs GroupDowngradeBuy ➝ NeutralHigh
i
3/21/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$244.00High
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
3/21/2019MizuhoDowngradeBuy ➝ Neutral$416.00 ➝ $235.00High
i
Rating by Salim Syed at Mizuho
3/21/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
i
3/21/2019BTIG ResearchDowngradeBuy ➝ NeutralHigh
i
3/21/2019CowenLower Price TargetOutperform$400.00 ➝ $275.00High
i
3/21/2019GuggenheimReiterated RatingNeutral ➝ Neutral$325.00High
i
3/21/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformHigh
i
3/21/2019Atlantic SecuritiesDowngradeOverweight ➝ NeutralHigh
i
3/21/2019William BlairDowngradeOutperform ➝ Market PerformHigh
i
Rating by M. Phipps at William Blair
3/21/2019Piper Jaffray CompaniesLower Price TargetMarket Perform ➝ Overweight$402.00 ➝ $280.00High
i
2/22/2019BMO Capital MarketsInitiated CoverageNeutral ➝ Market Perform$322.00Low
i
2/22/2019GuggenheimDowngradeBuy ➝ Neutral$410.00 ➝ $325.00Low
i
2/21/2019Stifel NicolausDowngradeBuy ➝ Hold$397.00 ➝ $346.00High
i
2/19/2019HC WainwrightReiterated RatingBuy$363.00Low
i
2/14/2019OppenheimerLower Price TargetOutperform$380.00 ➝ $375.00High
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
2/14/2019Royal Bank of CanadaReiterated RatingMarket PerformLow
i
2/12/2019Royal Bank of CanadaLower Price TargetSector Perform ➝ Fair Value$337.00 ➝ $318.00Low
i
1/30/2019CitigroupBoost Price TargetOutperform$372.00 ➝ $380.00High
i
1/30/2019SVB LeerinkBoost Price TargetMarket Perform$328.00 ➝ $341.00High
i
Rating by Geoff Porges at SVB Leerink LLC
1/29/2019MizuhoSet Price TargetBuy$427.00High
i
Rating by Salim Syed at Mizuho
1/29/2019Stifel NicolausBoost Price TargetBuy$392.00 ➝ $397.00Low
i
Rating by Alex Schwartz at Stifel Nicolaus
1/25/2019OppenheimerSet Price TargetBuy$372.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
1/10/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
12/26/2018BTIG ResearchInitiated CoverageBuyHigh
i
12/20/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$362.00High
i
12/19/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$394.00 ➝ $401.00Low
i
12/18/2018OppenheimerLower Price TargetOutperform$380.00 ➝ $372.00High
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
12/12/2018OppenheimerSet Price TargetBuy$380.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
12/12/2018Cantor FitzgeraldReiterated RatingBuy$400.00Low
i
Rating by A. Young at Cantor Fitzgerald
11/26/2018Royal Bank of CanadaLower Price TargetSector Perform$338.00Low
i
10/28/2018OppenheimerSet Price TargetBuy$400.00 ➝ $380.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
10/24/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Buy$445.00 ➝ $436.00High
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
10/24/2018SVB LeerinkSet Price TargetHold$328.00 ➝ $340.00High
i
10/23/2018Raymond JamesSet Price TargetBuy$400.00Medium
i
Rating by Laura Chico at Raymond James
10/23/2018MizuhoSet Price TargetBuy$427.00Low
i
Rating by Salim Syed at Mizuho
10/19/2018Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$373.00 ➝ $341.00High
i
10/19/2018OppenheimerSet Price TargetBuy$400.00High
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
10/8/2018CitigroupLower Price TargetBuy ➝ Buy$483.00 ➝ $470.00Low
i
10/3/2018Raymond JamesReiterated RatingBuyLow
i
Rating by Laura Chico at Raymond James
10/1/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00Low
i
Rating by William Tanner at Cantor Fitzgerald
9/16/2018OppenheimerSet Price TargetBuy$400.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
8/7/2018Stifel NicolausInitiated CoverageBuy$394.00High
i
Rating by Alex Schwartz at Stifel Nicolaus
7/31/2018MizuhoReiterated RatingBuy$427.00Low
i
Rating by Salim Syed at Mizuho
7/29/2018OppenheimerSet Price TargetBuy$400.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
7/26/2018CitigroupBoost Price TargetBuy ➝ Positive$483.00Medium
i
7/26/2018UBS GroupBoost Price TargetBuy ➝ Buy$354.00 ➝ $395.00Medium
i
7/25/2018Cantor FitzgeraldSet Price TargetHold$293.00Low
i
Rating by William Tanner at Cantor Fitzgerald
7/25/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$295.00 ➝ $320.00High
i
7/25/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$323.00 ➝ $348.00High
i
7/25/2018SunTrust BanksBoost Price TargetBuy$321.00 ➝ $392.00High
i
Rating by Yatin Suneja at SunTrust Banks, Inc.
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$366.00 ➝ $392.00High
i
7/24/2018GuggenheimReiterated RatingBuy$410.00High
i
Rating by Adnan Butt at Guggenheim
7/24/2018CowenReiterated RatingBuy$408.00High
i
7/24/2018MizuhoReiterated RatingBuy$423.00High
i
Rating by Salim Syed at Mizuho
7/24/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Hold$400.00 ➝ $445.00High
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
7/23/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$335.00 ➝ $396.00Low
i
Rating by Sumant Kulkarni at Canaccord Genuity
7/13/2018Morgan StanleyLower Price TargetOverweight$369.00 ➝ $366.00Low
i
7/11/2018Piper Jaffray CompaniesBoost Price TargetOverweight$365.00Low
i
7/10/2018Royal Bank of CanadaBoost Price TargetMarket Perform$349.00Medium
i
7/10/2018Robert W. BairdDowngradeOutperform ➝ Neutral$323.00Medium
i
7/9/2018UBS GroupDowngradeBuy ➝ HoldMedium
i
7/9/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Hold$400.00Medium
i
7/9/2018HC WainwrightReiterated RatingBuyMedium
i
7/8/2018OppenheimerSet Price TargetBuy$375.00 ➝ $400.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
7/6/2018Nomura SecuritiesReiterated RatingBuy$420.00High
i
7/6/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
7/6/2018Canaccord GenuitySet Price TargetBuy$335.00High
i
Rating by Sumant Kulkarni at Canaccord Genuity
7/6/2018CitigroupUpgradeNeutral ➝ Buy$371.00High
i
7/6/2018MizuhoSet Price TargetBuy$423.00High
i
Rating by Salim Syed at Mizuho
6/29/2018MizuhoSet Price TargetBuy$423.00Medium
i
Rating by Salim Syed at Mizuho
6/6/2018Canaccord GenuitySet Price TargetBuy$335.00Medium
i
Rating by Sumant Kulkarni at Canaccord Genuity
6/5/2018MizuhoSet Price TargetBuy$423.00Medium
i
Rating by Salim Syed at Mizuho
5/31/2018Canaccord GenuityUpgradeHold ➝ Buy$350.00 ➝ $335.00Low
i
Rating by Sumant Kulkarni at Canaccord Genuity
5/3/2018MizuhoSet Price TargetBuy$423.00Low
i
Rating by Salim Syed at Mizuho
5/2/2018CitigroupLower Price TargetNeutral ➝ Neutral$360.00 ➝ $290.00Low
i
4/26/2018Cantor FitzgeraldReiterated RatingNeutralMedium
i
4/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$365.00 ➝ $369.00Low
i
4/25/2018CitigroupReiterated RatingOutperform$400.00 ➝ $375.00High
i
4/25/2018SVB LeerinkSet Price TargetMarket Perform ➝ Hold$365.00 ➝ $325.00High
i
Rating by Geoff Porges at SVB Leerink LLC
4/25/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$388.00 ➝ $262.15High
i
4/25/2018Robert W. BairdUpgradeNeutral ➝ OutperformHigh
i
4/24/2018OppenheimerSet Price TargetBuy$375.00High
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
4/24/2018Stifel NicolausSet Price TargetBuy$425.00High
i
Rating by Alex Schwartz at Stifel Nicolaus
4/24/2018GuggenheimSet Price TargetBuy$385.00High
i
Rating by Adnan Butt at Guggenheim
4/24/2018Credit Suisse GroupSet Price TargetBuy$384.00High
i
Rating by Alethia Young at Credit Suisse Group AG
4/24/2018SunTrust BanksSet Price TargetBuy$321.00High
i
Rating by Yatin Suneja at SunTrust Banks, Inc.
4/24/2018Piper Jaffray CompaniesLower Price TargetOverweightHigh
i
4/24/2018CowenReiterated RatingBuy$408.00High
i
4/24/2018MizuhoSet Price TargetBuy$433.00High
i
Rating by Salim Syed at Mizuho
4/24/2018Jefferies Financial GroupReiterated RatingHold$375.00 ➝ $300.00High
i
4/17/2018Credit Suisse GroupSet Price TargetBuy$384.00Medium
i
Rating by Alethia Young at Credit Suisse Group AG
4/11/2018MizuhoSet Price TargetBuy$433.00Low
i
Rating by Salim Syed at Mizuho
4/10/2018Sanford C. BernsteinSet Price TargetBuy$318.00Medium
i
Rating by Aaron Gal at Sanford C. Bernstein
4/9/2018Canaccord GenuitySet Price TargetHold$350.00Medium
i
Rating by Sumant Kulkarni at Canaccord Genuity
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$395.00 ➝ $295.00High
i
3/12/2018MizuhoSet Price TargetBuy$433.00Medium
i
Rating by Salim Syed at Mizuho
3/12/2018Credit Suisse GroupReiterated RatingBuy$384.00Medium
i
Rating by Alethia Young at Credit Suisse Group AG
3/2/2018GuggenheimSet Price TargetBuy$400.00Low
i
Rating by Adnan Butt at Guggenheim
3/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$403.00 ➝ $393.00Low
i
2/16/2018ArgusDowngradeBuy ➝ HoldMedium
i
2/15/2018Canaccord GenuitySet Price TargetHold$350.00Low
i
Rating by Sumant Kulkarni at Canaccord Genuity
2/15/2018William BlairReiterated RatingBuyLow
i
Rating by Matt Phipps at William Blair
2/8/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
2/7/2018Credit Suisse GroupUpgradeBuy$384.00High
i
Rating by Alethia Young at Credit Suisse Group AG
2/7/2018Canaccord GenuityReiterated RatingHold$350.00High
i
Rating by Sumant Kulkarni at Canaccord Genuity
2/4/2018MizuhoReiterated RatingBuy ➝ Buy$400.00 ➝ $433.00High
i
Rating by Salim Syed at Mizuho
1/31/2018UBS GroupUpgradeNeutral ➝ Buy$352.59 ➝ $410.00Low
i
Rating by Carter Gould at UBS Group AG
1/26/2018OppenheimerBoost Price TargetOutperform ➝ Buy$380.00 ➝ $400.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
1/26/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy$373.00Low
i
1/26/2018Jefferies Financial GroupReiterated RatingHoldMedium
i
1/26/2018Royal Bank of CanadaBoost Price TargetSector Perform$347.00High
i
1/26/2018SunTrust BanksBoost Price TargetBuy$392.00High
i
1/26/2018HC WainwrightReiterated RatingBuy ➝ Buy$340.00 ➝ $363.00High
i
1/26/2018CowenReiterated RatingBuy$408.00High
i
1/25/2018BMO Capital MarketsReiterated RatingBuyHigh
i
1/25/2018Robert W. BairdReiterated RatingNeutral ➝ HoldHigh
i
1/25/2018JPMorgan Chase & Co.Set Price TargetBuy$378.00Medium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/25/2018The Goldman Sachs GroupSet Price TargetBuy$390.00Medium
i
1/24/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$340.00 ➝ $350.00Medium
i
Rating by Sumant Kulkarni at Canaccord Genuity
1/21/2018BarclaysReiterated RatingBuy$395.00Medium
i
1/18/2018MizuhoSet Price TargetBuy$400.00Low
i
Rating by Salim Syed at Mizuho
1/16/2018Canaccord GenuitySet Price TargetHold ➝ Hold$340.00 ➝ $350.00High
i
Rating by Sumant Kulkarni at Canaccord Genuity
1/16/2018CitigroupReiterated RatingOutperform$350.00 ➝ $380.00Medium
i
1/15/2018OppenheimerSet Price TargetBuy$380.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
1/5/2018Canaccord GenuitySet Price TargetHold$340.00High
i
Rating by Sumant Kulkarni at Canaccord Genuity
1/5/2018MizuhoSet Price TargetBuy$400.00High
i
Rating by Salim Syed at Mizuho
1/2/2018Piper Jaffray CompaniesReiterated RatingBuyHigh
i
12/30/2017Nomura SecuritiesBoost Price TargetBuy$355.00 ➝ $420.00N/A
i
12/22/2017Nomura SecuritiesBoost Price TargetBuy ➝ Buy$355.00 ➝ $420.00Low
i
12/21/2017MizuhoSet Price TargetBuy$400.00Low
i
Rating by Salim Syed at Mizuho
12/20/2017Canaccord GenuitySet Price TargetHold$340.00Low
i
Rating by Sumant Kulkarni at Canaccord Genuity
12/20/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$321.00 ➝ $385.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
12/18/2017Piper Jaffray CompaniesReiterated RatingBuy$390.00Low
i
12/5/2017Royal Bank of CanadaReiterated RatingHold$321.00Low
i
12/4/2017OppenheimerSet Price TargetBuy$350.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
11/28/2017OppenheimerSet Price TargetBuy$350.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
11/28/2017Sanford C. BernsteinSet Price TargetBuy$310.00 ➝ $318.00Medium
i
11/27/2017CowenReiterated RatingBuy$338.00Low
i
11/27/2017BMO Capital MarketsReiterated RatingBuy$385.00Low
i
11/27/2017JPMorgan Chase & Co.Set Price TargetBuy$378.00Medium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
11/27/2017MizuhoSet Price TargetBuy$400.00Medium
i
Rating by Salim Syed at Mizuho
11/22/2017OppenheimerReiterated RatingBuy$350.00N/A
i
11/13/2017MizuhoSet Price TargetBuy$400.00N/A
i
Rating by Salim Syed at Mizuho
11/9/2017OppenheimerInitiated CoverageOutperform$350.00 ➝ $350.00N/A
i
11/6/2017BMO Capital MarketsBoost Price TargetOutperform$381.00 ➝ $386.00N/A
i
10/27/2017Canaccord GenuityInitiated CoverageHold ➝ Hold$340.00N/A
i
10/25/2017HC WainwrightReiterated RatingBuy$340.00N/A
i
10/25/2017Royal Bank of CanadaLower Price TargetSector Perform ➝ Sector Perform$315.00 ➝ $313.00N/A
i
10/25/2017UBS GroupBoost Price TargetNeutral$285.00 ➝ $318.00N/A
i
Rating by Carter Gould at UBS Group AG
10/25/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$377.00N/A
i
10/24/2017SunTrust BanksReiterated RatingBuy$354.00N/A
i
10/24/2017Cantor FitzgeraldReiterated RatingHold$279.00N/A
i
10/23/2017GuggenheimInitiated CoverageBuy$402.00N/A
i
10/23/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ Overweight$390.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
10/23/2017CitigroupDowngradeBuy ➝ NeutralN/A
i
10/18/2017Bank of AmericaBoost Price TargetBuy$358.00 ➝ $365.00N/A
i
10/17/2017Morgan StanleyReiterated RatingBuyN/A
i
10/17/2017MizuhoUpgradeNeutral ➝ Buy$319.00 ➝ $400.00N/A
i
Rating by S. Syed at Mizuho
10/17/2017Stifel NicolausUpgradeHold ➝ Buy$300.00 ➝ $415.00N/A
i
10/12/2017Stifel NicolausReiterated RatingHold$300.00N/A
i
10/5/2017Royal Bank of CanadaReiterated RatingHold$315.00N/A
i
10/5/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$311.00 ➝ $375.00N/A
i
10/2/2017MizuhoReiterated RatingNeutral$319.00Low
i
9/21/2017Raymond JamesDowngradeStrong-Buy ➝ Market Perform$244.28 ➝ $319.00Low
i
9/20/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$360.00Low
i
9/14/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$319.00Medium
i
9/13/2017BMO Capital MarketsBoost Price TargetMarket Perform$328.00 ➝ $377.00Low
i
9/13/2017MizuhoReiterated RatingNeutral$274.00 ➝ $319.00Medium
i
Rating by Salim Syed at Mizuho
8/25/2017Robert W. BairdReiterated RatingHold$290.00Low
i
8/16/2017The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$338.00Low
i
7/27/2017CowenReiterated RatingBuyMedium
i
7/26/2017BMO Capital MarketsReiterated RatingMarket Perform$317.00 ➝ $328.00Medium
i
7/26/2017UBS GroupReiterated RatingNeutral$270.00 ➝ $285.00Low
i
Rating by Carter Gould at UBS Group AG
7/26/2017Morgan StanleyReiterated RatingEqual Weight$301.00 ➝ $311.00Low
i
7/26/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$315.00 ➝ $319.00Low
i
Rating by Andrew Peters at Deutsche Bank Aktiengesellschaft
7/26/2017SVB LeerinkReiterated RatingMarket Perform$304.00 ➝ $338.00High
i
Rating by Geoff Porges at SVB Leerink LLC
7/26/2017The Goldman Sachs GroupUpgradeNeutral ➝ Buy$228.00 ➝ $338.00High
i
7/18/2017BMO Capital MarketsReiterated RatingHold$318.00Low
i
7/14/2017Credit Suisse GroupSet Price TargetHold$300.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
7/11/2017Jefferies Financial GroupReiterated RatingHold ➝ Hold$310.00Low
i
Rating by David Steinberg at Jefferies Financial Group Inc.
7/10/2017Morgan StanleyReiterated RatingEqual WeightLow
i
7/3/2017CowenReiterated RatingOutperform$271.00Medium
i
6/26/2017William BlairReiterated RatingOutperformHigh
i
Rating by M. Phipps at William Blair
6/23/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$315.00Low
i
6/22/2017SVB LeerinkReiterated RatingMarket PerformLow
i
Rating by Geoff Porges at SVB Leerink LLC
6/19/2017UBS GroupUpgradeSell ➝ Neutral$262.00 ➝ $270.00N/A
i
6/14/2017Morgan StanleyReiterated RatingEqual Weight$307.00Low
i
6/2/2017BMO Capital MarketsReiterated RatingHold$318.00Medium
i
Rating by Do Kim at BMO Capital Markets
5/31/2017MizuhoLower Price TargetNeutral$290.00 ➝ $274.00Low
i
Rating by Salim Syed at Mizuho
5/25/2017Sanford C. BernsteinReiterated RatingOutperformLow
i
5/25/2017Cantor FitzgeraldReiterated RatingHold$277.00Low
i
Rating by William Tanner at Cantor Fitzgerald
5/15/2017Piper Jaffray CompaniesSet Price TargetBuy$332.00 ➝ $442.00Low
i
Rating by Joshua Schimmer at Piper Jaffray Companies
4/27/2017MizuhoReiterated RatingHoldMedium
i
Rating by Salim Syed at Mizuho
4/26/2017Stifel NicolausBoost Price TargetHold$265.00 ➝ $280.00Medium
i
Rating by Thomas Shrader at Stifel Nicolaus
4/25/2017CowenReiterated RatingBuy$338.00High
i
4/25/2017Cantor FitzgeraldSet Price TargetHold$278.00Low
i
Rating by William Tanner at Cantor Fitzgerald
4/25/2017Sanford C. BernsteinReiterated RatingOutperform$310.00Medium
i
4/23/2017BarclaysReiterated RatingOverweight$380.00 ➝ $360.00Medium
i
4/18/2017MizuhoReiterated RatingHold$290.00Low
i
Rating by Salim Syed at Mizuho
4/18/2017Robert W. BairdReiterated RatingNeutral$290.00Low
i
Rating by Brian Skorney at Robert W. Baird
4/10/2017SVB LeerinkLower Price TargetMarket Perform$300.00 ➝ $290.00Low
i
Rating by Geoff Porges at SVB Leerink LLC
4/4/2017Jefferies Financial GroupSet Price TargetHold$289.00Low
i
Rating by David Steinberg at Jefferies Financial Group Inc.
4/4/2017CitigroupBoost Price TargetBuy$305.00 ➝ $315.00Low
i
4/3/2017SVB LeerinkSet Price TargetHold$300.00Low
i
Rating by Geoff Porges at SVB Leerink LLC
4/3/2017Credit Suisse GroupReiterated RatingNeutral$296.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
4/3/2017MizuhoReiterated RatingNeutral$290.00Low
i
Rating by Salim Syed at Mizuho
3/29/2017Cantor FitzgeraldReiterated RatingNeutralHigh
i
Rating by W. Tanner at Cantor Fitzgerald
3/29/2017Robert W. BairdReiterated RatingNeutral$290.00Low
i
Rating by Brian Skorney at Robert W. Baird
3/22/2017MizuhoReiterated RatingNeutral$290.00Low
i
Rating by Salim Syed at Mizuho
3/16/2017SVB LeerinkDowngradeOutperform ➝ Market Perform$300.00High
i
Rating by Geoff Porges at SVB Leerink LLC
3/16/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$369.00 ➝ $305.00High
i
3/11/2017UBS GroupReiterated RatingSell$260.00N/A
i
3/7/2017Robert W. BairdReiterated RatingNeutral$290.00N/A
i
Rating by Brian Skorney at Robert W. Baird
3/1/2017Nomura InstinetInitiated CoverageBuy ➝ Buy$223.03 ➝ $345.00N/A
i
3/1/2017Nomura SecuritiesInitiated CoverageNeutralN/A
i
2/24/2017Sanford C. BernsteinReiterated RatingOutperform$310.00N/A
i
2/11/2017Credit Suisse GroupSet Price TargetHold$296.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
2/7/2017CitigroupUpgradeNeutral ➝ Buy$305.00N/A
i
2/7/2017Robert W. BairdReiterated RatingHoldN/A
i
Rating by Brian Skorney at Robert W. Baird
2/6/2017MizuhoReiterated RatingSellN/A
i
Rating by Salim Syed at Mizuho
2/4/2017Credit Suisse GroupSet Price TargetHold$296.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
2/2/2017Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by Michael Yee at Royal Bank of Canada
1/30/2017HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
1/27/2017Morgan StanleyBoost Price TargetOverweight$353.00 ➝ $369.00N/A
i
1/26/2017Cantor FitzgeraldSet Price TargetHold$293.00N/A
i
Rating by William Tanner at Cantor Fitzgerald
1/24/2017Credit Suisse GroupSet Price TargetHold$314.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
1/24/2017BMO Capital MarketsReiterated RatingMarket Perform$336.00N/A
i
Rating by Do Kim at BMO Capital Markets
1/24/2017Jefferies Financial GroupReiterated RatingHold$313.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
1/18/2017SVB LeerinkSet Price TargetBuy$360.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
1/18/2017Cantor FitzgeraldReiterated RatingHold$293.00N/A
i
1/18/2017Jefferies Financial GroupReiterated RatingHoldN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
1/18/2017JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by cory kasimov at JPMorgan Chase & Co.
1/18/2017MizuhoReiterated RatingHold$290.00N/A
i
Rating by Salim Syed at Mizuho
1/17/2017Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
1/17/2017Robert W. BairdReiterated RatingPositive$309.00N/A
i
1/17/2017Stifel NicolausSet Price TargetHold$298.00N/A
i
1/8/2017BMO Capital MarketsSet Price TargetHold$336.00N/A
i
Rating by Do Kim at BMO Capital Markets
1/8/2017Jefferies Financial GroupReiterated RatingHold$312.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
1/6/2017Cantor FitzgeraldReiterated RatingHoldN/A
i
12/30/2016CowenReiterated RatingBuy$368.00N/A
i
12/30/2016Credit Suisse GroupReiterated RatingNeutral$312.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
12/29/2016Raymond JamesBoost Price TargetStrong-Buy$375.00 ➝ $386.00N/A
i
12/28/2016JPMorgan Chase & Co.Reiterated RatingOverweight$384.00N/A
i
Rating by cory kasimov at JPMorgan Chase & Co.
12/27/2016SVB LeerinkReiterated RatingOutperform$355.00 ➝ $368.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
12/23/2016Robert W. BairdReiterated RatingNeutral$309.00N/A
i
12/22/2016BMO Capital MarketsReiterated RatingMarket Perform$328.00N/A
i
12/21/2016Jefferies Financial GroupReiterated RatingHold$310.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
12/21/2016CowenReiterated RatingOutperform$368.00N/A
i
12/20/2016Credit Suisse GroupReiterated RatingHold$312.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
12/15/2016Cantor FitzgeraldInitiated CoverageNeutral$293.00N/A
i
12/12/2016HC WainwrightSet Price TargetBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
12/10/2016MizuhoSet Price TargetHold$290.00N/A
i
Rating by Salim Syed at Mizuho
12/9/2016Jefferies Financial GroupSet Price TargetHold$310.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
12/9/2016Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
12/9/2016Robert W. BairdReiterated RatingNeutral$284.00 ➝ $309.00N/A
i
Rating by Brian Skorney at Robert W. Baird
12/9/2016Stifel NicolausBoost Price TargetHold$291.00 ➝ $298.00N/A
i
12/4/2016BMO Capital MarketsReiterated RatingMarket Perform$294.00 ➝ $331.00N/A
i
12/1/2016MizuhoReiterated RatingHold$290.00N/A
i
11/26/2016Robert W. BairdReiterated RatingNeutral$284.00N/A
i
Rating by Brian Skorney at Robert W. Baird
11/26/2016BMO Capital MarketsReiterated RatingMarket Perform$294.00N/A
i
11/25/2016SVB LeerinkLower Price TargetOutperform$365.00 ➝ $355.00N/A
i
Rating by G. Porges at SVB Leerink LLC
11/24/2016Credit Suisse GroupSet Price TargetHold$322.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
11/24/2016Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
11/7/2016MizuhoInitiated CoverageNeutral$290.00N/A
i
11/7/2016SVB LeerinkUpgradeMarket Perform ➝ OutperformN/A
i
Rating by Geoff Porges at SVB Leerink LLC
11/7/2016Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$335.00N/A
i
Rating by joshua schimmer at Piper Jaffray Companies
10/27/2016HC WainwrightReiterated RatingBuyN/A
i
Rating by Andrew Fein at HC Wainwright
10/27/2016SVB LeerinkReiterated RatingMarket Perform$367.00 ➝ $361.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
10/26/2016CowenReiterated RatingBuy$368.00N/A
i
Rating by Eric Schmidt at Cowen Inc
10/12/2016SVB LeerinkSet Price TargetHold$367.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
10/12/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
10/7/2016JPMorgan Chase & Co.Reiterated RatingOverweight$386.00N/A
i
Rating by cory kasimov at JPMorgan Chase & Co.
10/5/2016Jefferies Financial GroupLower Price TargetHold$323.00 ➝ $316.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
10/4/2016BMO Capital MarketsReiterated RatingMarket Perform$304.00N/A
i
10/4/2016Royal Bank of CanadaReiterated RatingBuy$375.00N/A
i
9/22/2016Piper Jaffray CompaniesSet Price TargetHold$333.00N/A
i
Rating by joshua schimmer at Piper Jaffray Companies
9/22/2016Bank of AmericaReiterated RatingBuy$374.00N/A
i
Rating by Ying Huang at Bank of America Co.
9/20/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
9/18/2016Credit Suisse GroupSet Price TargetHold$322.00N/A
i
Rating by alethia young at Credit Suisse Group AG
9/16/2016JPMorgan Chase & Co.Reiterated RatingBuy$386.00N/A
i
9/16/2016Stifel NicolausReiterated RatingHoldN/A
i
Rating by Thomas Shrader at Stifel Nicolaus
9/8/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
9/6/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$323.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
9/4/2016Jefferies Financial GroupReiterated RatingBuy ➝ Buy$319.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
8/17/2016Morgan StanleyLower Price TargetOverweight$385.00 ➝ $368.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
8/16/2016Piper Jaffray CompaniesReiterated RatingNeutral$293.00 ➝ $333.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
8/10/2016Robert W. BairdReiterated RatingNeutral$284.00N/A
i
Rating by Brian Skorney at Robert W. Baird
8/9/2016SVB LeerinkReiterated RatingHold$367.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
8/4/2016Jefferies Financial GroupReiterated RatingBuy$319.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
8/3/2016Piper Jaffray CompaniesReiterated RatingNeutralN/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
8/3/2016Morgan StanleyReiterated RatingBuy$385.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
8/3/2016Credit Suisse GroupReiterated RatingHold$322.00N/A
i
8/2/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
i
8/2/2016Raymond JamesBoost Price TargetStrong-Buy$360.00 ➝ $375.00N/A
i
8/1/2016Robert W. BairdReiterated RatingPositive$268.00 ➝ $284.00N/A
i
Rating by Brian Skorney at Robert W. Baird
8/1/2016SVB LeerinkBoost Price TargetMarket Perform$360.00 ➝ $367.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
8/1/2016BMO Capital MarketsBoost Price TargetMarket Perform$286.00 ➝ $304.00N/A
i
7/26/2016Jefferies Financial GroupReiterated RatingBuy$319.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
7/25/2016Robert W. BairdReiterated RatingNeutral$268.00N/A
i
Rating by Brian Skorney at Robert W. Baird
7/24/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
7/24/2016BMO Capital MarketsReiterated RatingMarket Perform$287.00N/A
i
7/24/2016SVB LeerinkReiterated RatingMarket Perform$319.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
7/22/2016Credit Suisse GroupReiterated RatingHold$312.00N/A
i
7/21/2016Piper Jaffray CompaniesSet Price TargetHold$293.00N/A
i
Rating by ">Joshua Schimmer at Piper Jaffray Companies
7/21/2016Morgan StanleyBoost Price TargetOverweight$383.00 ➝ $385.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
7/13/2016Jefferies Financial GroupReiterated RatingBuy$317.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
6/30/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Matthew Harrison at Morgan Stanley
6/30/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
6/30/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Geoff Porges at SVB Leerink LLC
6/30/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Ying Huang at Bank of America Co.
6/29/2016Sanford C. BernsteinInitiated CoverageOutperform$282.00N/A
i
6/22/2016Robert W. BairdReiterated RatingNeutral$268.00N/A
i
Rating by Brian Skorney at Robert W. Baird
6/8/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by Michael Yee at Royal Bank of Canada
6/8/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
6/8/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
6/8/2016BMO Capital MarketsReiterated RatingMarket Perform$287.00N/A
i
6/7/2016Piper Jaffray CompaniesReiterated RatingHold$293.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
6/7/2016SVB LeerinkReiterated RatingMarket Perform$319.00N/A
i
Rating by Sahar Wolff at SVB Leerink LLC
6/7/2016CitigroupDowngradeBuy ➝ Neutral$345.00 ➝ $295.00N/A
i
Rating by Robyn Karnauskas at Citigroup Inc.
6/1/2016SVB LeerinkReiterated RatingMarket Perform$319.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
5/29/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
5/26/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
5/16/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Brian Skorney at Robert W. Baird
5/3/2016SVB LeerinkReiterated RatingPositive$319.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
5/3/2016Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
4/25/2016SVB LeerinkReiterated RatingMarket Perform$328.00 ➝ $319.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
4/24/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
4/23/2016The Goldman Sachs GroupReiterated RatingHoldN/A
i
Rating by Terence Flynn at The Goldman Sachs Group, Inc.
4/21/2016Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
4/21/2016The Goldman Sachs GroupBoost Price TargetNeutral$271.00 ➝ $285.00N/A
i
4/21/2016Stifel NicolausReiterated RatingHoldN/A
i
4/18/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Geoff Porges at SVB Leerink LLC
4/17/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
4/15/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Brian Skorney at Robert W. Baird
4/12/2016SVB LeerinkReiterated RatingMarket Perform$328.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
4/11/2016CitigroupReiterated RatingBuy$345.00N/A
i
Rating by Robyn Karnauskas at Citigroup Inc.
4/8/2016Morgan StanleyLower Price Target$419.00 ➝ $404.00N/A
i
4/6/2016Jefferies Financial GroupLower Price TargetBuy$325.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
4/5/2016BMO Capital MarketsInitiated CoverageMarket Perform$283.00N/A
i
3/28/2016SVB LeerinkReiterated RatingMarket Perform$335.00 ➝ $328.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
3/23/2016Jefferies Financial GroupReiterated RatingBuy$338.00N/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
3/16/2016SVB LeerinkReiterated RatingMarket Perform$335.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
3/11/2016Robert W. BairdReiterated RatingNeutral$292.00 ➝ $268.00N/A
i
2/25/2016CitigroupInitiated CoverageBuy$345.00N/A
i
2/22/2016The Goldman Sachs GroupLower Price Target$293.00 ➝ $272.00N/A
i
2/18/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
2/6/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Geoff Porges at SVB Leerink LLC
2/4/2016SVB LeerinkInitiated CoverageMarket Perform$335.00N/A
i
Rating by Joseph Schwartz at SVB Leerink LLC
2/1/2016HC WainwrightReiterated RatingBuy$360.00N/A
i
Rating by Andrew Fein at HC Wainwright
1/28/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Abrahams at Jefferies Financial Group Inc.
1/27/2016JPMorgan Chase & Co.Reiterated RatingOverweight$403.00N/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/27/2016William BlairReiterated RatingOutperformN/A
i
1/27/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
1/27/2016Piper Jaffray CompaniesReiterated RatingNeutral$293.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
1/22/2016BarclaysReiterated RatingBuy$420.00N/A
i
Rating by Geoff Meacham at Barclays PLC
1/22/2016Wells Fargo & CompanyReiterated RatingOutperformN/A
i
1/19/2016Credit Suisse GroupInitiated CoverageNeutral$322.00N/A
i
1/12/2016JPMorgan Chase & Co.Reiterated RatingOverweightN/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/7/2016Standpoint ResearchInitiated CoverageBuy$360.00N/A
i
1/4/2016CowenReiterated RatingBuy$368.00N/A
i
Rating by Eric Schmidt at Cowen Inc
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$344.00N/A
i
12/3/2015Wells Fargo & CompanyInitiated CoverageOutperformN/A
i
(Data available from 12/3/2015 forward)
Biogen logo
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it is involved in developing Opicinumab, BIIB061, and BIIB091 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB110, and BIIB100 to treat neuromuscular disorders; BIIB054 and BIIB094 for treating movement disorders; BIIB111 and BIIB112 for ophthalmology; Dapirolizumab pegol and BIIB059 to treat immunology and others; BIIB104 for neurocognitive disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB074 and BIIB095 for pain; and SB11 biosimilar, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration agreements with Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Eisai Co., Ltd.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Acorda Therapeutics, Inc.; AbbVie Inc.; Skyhawk Therapeutics, Inc.; Neurimmune SubOne AG; Scribe Therapeutics Inc.; and Sangamo Therapeutics Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $244.09
$243.20
$249.21

50 Day Range

MA: $261.07
$236.26
$355.63

52 Week Range

Now: $244.09
$223.25
$374.99

Volume

846,787 shs

Average Volume

1,740,726 shs

Market Capitalization

$37.56 billion

P/E Ratio

8.08

Dividend Yield

N/A

Beta

0.52